Barbara C. Vanderhyden

11.7k total citations
151 papers, 7.5k citations indexed

About

Barbara C. Vanderhyden is a scholar working on Molecular Biology, Reproductive Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Barbara C. Vanderhyden has authored 151 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 48 papers in Reproductive Medicine and 45 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Barbara C. Vanderhyden's work include Reproductive Biology and Fertility (45 papers), Ovarian cancer diagnosis and treatment (30 papers) and Virus-based gene therapy research (12 papers). Barbara C. Vanderhyden is often cited by papers focused on Reproductive Biology and Fertility (45 papers), Ovarian cancer diagnosis and treatment (30 papers) and Virus-based gene therapy research (12 papers). Barbara C. Vanderhyden collaborates with scholars based in Canada, United States and China. Barbara C. Vanderhyden's co-authors include David P. Cook, David T. Armstrong, Roberto Buccione, Tanya J. Shaw, Gerald M. Kidder, Fiona H. Thomas, Paul Morley, Kenneth Garson, Mary K. Senterman and Elizabeth A. Macdonald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Barbara C. Vanderhyden

147 papers receiving 7.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara C. Vanderhyden Canada 49 3.6k 2.6k 2.5k 1.4k 1.3k 151 7.5k
Andrea Jurisicova Canada 47 3.3k 0.9× 3.7k 1.4× 2.9k 1.1× 800 0.6× 620 0.5× 87 7.6k
Nelly Auersperg Canada 50 4.5k 1.3× 1.4k 0.5× 2.9k 1.2× 1.5k 1.0× 1.9k 1.4× 195 8.8k
Bo R. Rueda United States 47 2.7k 0.7× 925 0.4× 1.5k 0.6× 570 0.4× 1.7k 1.3× 155 6.5k
Cristin G. Print New Zealand 40 3.7k 1.0× 507 0.2× 1.2k 0.5× 669 0.5× 1.1k 0.8× 149 7.8k
Santo V. Nicosia United States 43 4.6k 1.3× 657 0.3× 1.4k 0.5× 1.0k 0.7× 2.2k 1.7× 117 8.6k
Reiner Strick Germany 38 2.6k 0.7× 630 0.2× 456 0.2× 572 0.4× 785 0.6× 117 5.2k
Hidemichi Watari Japan 47 3.3k 0.9× 329 0.1× 1.7k 0.7× 453 0.3× 1.4k 1.1× 210 7.5k
Wojciech Gorczyca United States 33 4.0k 1.1× 606 0.2× 501 0.2× 384 0.3× 1.2k 0.9× 120 7.2k
Leslie Cope United States 41 6.7k 1.9× 408 0.2× 694 0.3× 1.1k 0.8× 1.9k 1.5× 132 10.3k
Bernard Haendler Germany 40 3.6k 1.0× 344 0.1× 485 0.2× 896 0.6× 926 0.7× 110 5.4k

Countries citing papers authored by Barbara C. Vanderhyden

Since Specialization
Citations

This map shows the geographic impact of Barbara C. Vanderhyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara C. Vanderhyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara C. Vanderhyden more than expected).

Fields of papers citing papers by Barbara C. Vanderhyden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara C. Vanderhyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara C. Vanderhyden. The network helps show where Barbara C. Vanderhyden may publish in the future.

Co-authorship network of co-authors of Barbara C. Vanderhyden

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara C. Vanderhyden. A scholar is included among the top collaborators of Barbara C. Vanderhyden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara C. Vanderhyden. Barbara C. Vanderhyden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodriguez, Galaxia M., Elizabeth A. Macdonald, Mélanie Grondin, et al.. (2025). Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer. Molecular Cancer Therapeutics. 24(10). 1626–1639.
2.
Zhu, Yalun, Atefeh Abedini, Galaxia M. Rodriguez, et al.. (2025). Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression. Oncogene. 44(27). 2240–2252. 1 indexed citations
3.
Cook, David P., Barbara C. Vanderhyden, Jin G. Park, et al.. (2024). Transcriptional regulation of the postnatal cardiac conduction system heterogeneity. Nature Communications. 15(1). 6550–6550. 3 indexed citations
4.
Rodriguez, Galaxia M., David P. Cook, Elizabeth A. Macdonald, et al.. (2024). FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models. Scientific Reports. 14(1). 787–787. 7 indexed citations
5.
Cyr-Depauw, Chanèle, David P. Cook, Flore Lesage, et al.. (2024). Single-Cell RNA Sequencing Reveals Repair Features of Human Umbilical Cord Mesenchymal Stromal Cells. American Journal of Respiratory and Critical Care Medicine. 210(6). 814–827. 6 indexed citations
6.
Cyr-Depauw, Chanèle, David P. Cook, Flore Lesage, et al.. (2024). Single-Cell RNA Sequencing to Guide Autologous Preterm Cord Mesenchymal Stromal Cell Therapy. American Journal of Respiratory and Critical Care Medicine. 211(3). 391–406.
7.
Hodgins, Jonathan J., et al.. (2023). Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses. Cells. 13(1). 73–73. 2 indexed citations
8.
Salehi, Reza, Brandon A. Wyse, Meshach Asare-Werehene, et al.. (2023). Androgen-induced exosomal miR-379-5p release determines granulosa cell fate: cellular mechanism involved in polycystic ovaries. Journal of Ovarian Research. 16(1). 74–74. 10 indexed citations
9.
Wong, Boaz, Daniel Serrano, Zaid Taha, et al.. (2023). Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy. Molecular Therapy. 31(11). 3176–3192. 11 indexed citations
10.
Cook, David P., Galaxia M. Rodriguez, Kathy Matuszewska, et al.. (2023). Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer. Communications Biology. 6(1). 1152–1152. 11 indexed citations
11.
Rodriguez, Galaxia M., et al.. (2022). The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research. Cancer Research Communications. 2(6). 417–433. 15 indexed citations
12.
Mižíková, Ivana, Flore Lesage, Chanèle Cyr-Depauw, et al.. (2021). Single-Cell RNA Sequencing-Based Characterization of Resident Lung Mesenchymal Stromal Cells in Bronchopulmonary Dysplasia. Stem Cells. 40(5). 479–492. 14 indexed citations
13.
Arulanandam, Rozanne, Zaid Taha, Vanessa da Silva Garcia, et al.. (2020). The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy. Communications Biology. 3(1). 254–254. 11 indexed citations
14.
Salem, Mohamed A., Jacob A. O’Brien, Stefanie Bernaudo, et al.. (2018). miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2–Versican Pathway. Cancer Research. 78(15). 4175–4190. 78 indexed citations
15.
Vanderhyden, Barbara C., et al.. (2017). 17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression. Scientific Reports. 7(1). 16702–16702. 8 indexed citations
16.
Tang, Yong, et al.. (2015). Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer. Cancer Prevention Research. 8(12). 1163–1173. 21 indexed citations
17.
Garson, Kenneth, et al.. (2010). 17β-Estradiol Accelerates Tumor Onset and Decreases Survival in a Transgenic Mouse Model of Ovarian Cancer. Endocrinology. 151(3). 929–938. 49 indexed citations
18.
Garson, Kenneth, et al.. (2005). Models of ovarian cancer—Are we there yet?. Molecular and Cellular Endocrinology. 239(1-2). 15–26. 53 indexed citations
19.
Vanderhyden, Barbara C.. (2002). Molecular basis of ovarian development and function. Frontiers in bioscience. 7(4). d2006–2022. 45 indexed citations
20.
Nagyová, Eva, Radek Procházka, & Barbara C. Vanderhyden. (1999). Oocytectomy Does Not Influence Synthesis of Hyaluronic Acid by Pig Cumulus Cells: Retention of Hyaluronic Acid After Insulin-Like Growth Factor-I Treatment in Serum-Free Medium1. Biology of Reproduction. 61(3). 569–574. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Jurisicova Breakdown of academic impact, for papers by Nelly Auersperg Breakdown of academic impact, for papers by Bo R. Rueda Breakdown of academic impact, for papers by Cristin G. Print Breakdown of academic impact, for papers by Santo V. Nicosia Breakdown of academic impact, for papers by Reiner Strick Breakdown of academic impact, for papers by Hidemichi Watari Breakdown of academic impact, for papers by Wojciech Gorczyca Breakdown of academic impact, for papers by Leslie Cope Breakdown of academic impact, for papers by Bernard Haendler
Rankless by CCL
2026